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Abstract:  250 words 
Disorders of dysregulated negative emotion such as depression and anxiety also feature increased 
cardiovascular mortality and decreased heart-rate variability (HRV).These disorders are correlated with 
dysfunction within areas 25 and 32 of the ventromedial prefrontal cortex (vmPFC), but a causal 
relationship between dysregulation of these areas and such symptoms has not been demonstrated. 
Furthermore, cross-species translation is limited by inconsistent findings between rodent fear extinction 
and human neuroimaging studies of negative emotion. To reconcile these literatures we applied a novel 
investigative approach to the brain-body interactions at the core of negative emotional dysregulation. We 
show that in marmoset monkeys (a non-human primate which has far greater vmPFC homology to humans 
than rodents), areas 25 and 32 have causal yet opposing roles in regulating the cardiovascular and 
behavioural correlates of negative emotion. In novel Pavlovian fear conditioning and extinction 
paradigms, pharmacological inactivation of area 25 decreased the autonomic and behavioural correlates 
of negative emotion expectation, while inactivation of area 32 increased them via generalisation. Area 25 
inactivation also increased resting HRV. These findings are inconsistent with current theories of 
rodent/primate prefrontal functional similarity, and provide new insight into the role of these brain 
regions in affective disorders. They demonstrate for the first time that area 32 hypoactivity causes 
behavioural generalisation relevant to anxiety, and that area 25 is a causal node governing both the 
emotional and cardiovascular symptomatology relevant to anxiety and depression. 
 
Significance Statement  
Affective disorders are associated with increased cardiovascular mortality and enhanced negative 
emotion. While neuroimaging studies of such disorders reveal dysregulation in numerous frontal brain 
regions including the subgenual/perigenual cingulate cortices (areas 25 and 32), the causal involvement 
of this dysregulation is unknown, and translation from rodent studies is limited. Here we demonstrate 
that in the marmoset monkey, inactivation of area 25 increases parasympathetic modulation of resting 
cardiovascular function, and decreases the cardiovascular and behavioural correlates of negative 
emotion. In contrast area 32 inactivation increases these correlates. These findings provide the first direct 
evidence that these primate areas differentially regulate negative emotion, and link the cardiovascular 





The ventromedial prefrontal cortex (vmPFC) including the anterior cingulate cortex (ACC), has emerged 
as a key node within the network of brain regions implicated in the regulation of negative emotion. 
Correlational imaging studies have consistently identified morphological and functional abnormalities in 
human vmPFC in a range of affective disorders associated with negative emotion dysregulation (1–5). 
Most prominently, depression has been linked to hyperactivity in caudal subgenual (sg)ACC (centred on 
area 25) and hypoactivity in perigenual (pg)ACC (centred on area 32 but also including to varying extents 
areas 10, 24 and 14), which are reversed following successful treatment with pharmacological and 
psychological therapies, as well as deep brain stimulation (DBS) targeting area 25 (6, 7),  Alterations in 
both pgACC and sgACC activity and sgACC grey matter volume are also seen, however, in generalised 
anxiety disorder (GAD), post-traumatic stress disorder, phobia, and in response to successful psychological 
therapy for GAD (8–11), indicating a more generalised role for these regions in the regulation of negative 
emotion. A neuroimaging meta-analysis of the vmPFC has proposed that activity in caudal sgACC is 
associated primarily with negative affect whilst activity in  more anterior regions that include areas 32, 24  
and 10 are associated primarily with positive affect (12). Notably, the vmPFC also responds to stimulation 
of the vagus nerve, the primary parasympathetic regulator of the cardiac cycle. and vmPFC blood flow 
correlates with heart rate variability (HRV), a parasympathetic-controlled index of cardiac autonomic 
function that is chronically low in affective disorders such as depression and anxiety (13–15). This 
anatomical overlap may explain the strong bi-directional association between affective disorders and 
cardiovascular dysfunction, such as the increased risk of ischaemic heart disease in depression (14, 16, 
17). 
Despite this wealth of correlative evidence, the causal contribution of the vmPFC to dysregulation of 
negative emotion, and in particular the independent roles of the component brain regions that together 
comprise vmPFC, are poorly understood. Indeed, these changes in area 25 and 32 activity may not 
necessarily be a primary cause of negative emotion dysregulation. Instead, they could reflect 
compensatory changes caused by dysfunction in other areas of the PFC that are causing affective 
symptoms, or represent a correlate of decisions made elsewhere in the vmPFC about the individual’s 
affective state (18). Addressing this issue of causality is vital to refine our understanding of affective 
disorders, and for the development of novel, more targeted treatments. While stimulation throughout 
the ACC has been shown to induce autonomic changes in humans, such cardiovascular or emotional 
effects cannot be specifically attributed to a particular area (19) without targeted interventions.  
Such targeted interventions have primarily been made in rodents studying the role of the medial PFC in 
fear conditioning and extinction. These studies have largely ignored the cardiovascular components that 
are a characteristic feature of depression and anxiety (but see , 20, 21) and have focused primarily on the 
behavioural correlates of negative emotion. Importantly, these behavioural findings related to rodent fear 
cannot currently be reconciled with the human neuroimaging data discussed above. The rodent mPFC 
consists of infralimbic (IL) and prelimbic (PL) subregions, whose anatomical connectivity is very similar to 
that of primate areas 25 and 32 respectively (22–24). Given this similarity in connectivity, comparable 
functions would also be predicted. However, although these regions are differentially involved in the 
regulation of a conditioned negative emotional response, the similarities end there. IL neurons are active 
during recall of extinction, and both lesions and temporary inactivation of the IL enhance conditioned fear 
and inhibit extinction recall, leading to the hypothesis that the IL is associated with the recall (and storage; 
, 25) of extinction memory (12, 26–29). In contrast, activity in PL is associated with the expression of 
conditioned fear (12, 26–28, 30). Thus activity in the IL and PL have opposite effects to the activity of areas 
25 and 32 in humans, with IL activity reducing negative emotional responding (compared to the increase 
seen with area 25 activity) and PL activity increasing negative emotional responding in the rodent 
(compared to the increased positive affect associated with area 32) (26, 31). Furthermore, the rodent data 
are also inconsistent with the neuroimaging of fear extinction in humans where the focus of activity 
related to extinction recall is far more rostral than area 25 (32). In light of the failure to develop major 
new psychopharmacological treatments for the affective disorders over the last twenty years (33), these 
cross-species behavioural inconsistencies raise serious questions about the translational relevance of 
rodent medial PFC conditioned fear studies to our understanding of these regions in the primate brain. 
To resolve these discrepancies a new experimental approach is required which takes into account the 
brain-body interactions at the core of emotion and uses a non-human primate in which there is far greater 
prefrontal homology to humans than rodents. This allows the investigation of primate areas 25 and 32, 
on classic rodent tasks of conditioned fear that implicate the IL and PL in order to bridge the translational 
gap in our current understanding. Here we describe the effects of temporarily inactivating areas 25 and 
32 selectively in marmoset monkeys on both behavioural and cardiovascular indices of negative emotion. 
Marmoset monkeys were tested in three paradigms: i) an emotionally neutral condition, ii) a novel version 
of a mildly aversive Pavlovian discrimination task (34) in which the probability of receiving an aversive 
loud noise was predicted differentially by three distinct auditory cues, and iii) a novel adaptation of the 
classic rodent fear conditioning and extinction paradigm in which the sight of a rubber snake replaces 
footshock (26). We used real-time telemetric cardiovascular monitoring (35) and behavioural assessment, 
combined with anatomically specific intracerebral infusions of γ-aminobutyric acid (GABA) agonists  that 
temporarily inactivate cell bodies, nerve terminals and glia, without affecting fibres of passage (36) (or 
saline control), and anxiolytic drug treatment with diazepam (Figure 1).  
 
Results 
Area 25 regulates baseline cardiovascular activity via the parasympathetic system 
To assess the impact of area 25 and area 32 inactivation on cardiovascular regulation, animals were 
assessed first in a familiar, emotionally neutral environment and their cardiovascular function measured 
in the absence of any cues (n = 13; Figure 1A). Bilateral inactivation of areas 25 and 32 with 0.5 μL of 0.1 
mM muscimol/1.0 mM baclofen had different autonomic effects (Figure 2). Inactivation of area 25 
decreased heart rate (HR) and mean arterial blood pressure (MAP) and increased HRV, while inactivation 
of area 32 only increased MAP. HRV reflects the balance between the parasympathetic (vagal) and 
sympathetic autonomic regulation of the heart. Consequently, we fractionated our HRV measure into the 
cardiac vagal (CVI) and sympathetic (CSI) indices (37). Area 25 inactivation selectively increased CVI 
without changing the CSI (Figure 2D), indicating that alterations in HRV and cardiac vagal control can be 
specifically linked to area 25 dysfunction. 
 
Area 25 inactivation reduces, and area 32 inactivation enhances, aversive Pavlovian conditioned 
responding 
To assess the impact of area 25 and 32 inactivation on the regulation of negative emotion, a subset of 
monkeys then learned the novel aversive Pavlovian conditioned discrimination (Figure 1B/C) in which 
three auditory CSs predicted an aversive loud noise with 100%, 50% or 0% probability. Loud noise is 
frequently used as an aversive cue in humans (38), and has been used in non-human primates as an 
alternative to the footshock used in non-primate species (39). In marmosets, loud noise causes 
punishment-induced suppression of responding (40), and response generalisation in high trait anxious 
individuals (41), similar to that seen in humans and rats. In addition, there is no evidence of habituation 
to the loud noise, with conditioned responses being maintained across repeated sessions (Figure 3C), and, 
most critically, loud noise is avoided in instrumental choice tasks (42; Figure S1). Multiple lines of evidence 
therefore indicate that the loud noise has aversive value, rather than just being salient. As animals learned 
this auditory discrimination, both their CS-directed HR and CS-directed behavioural orienting (vigilant 
scanning, VS) increased in proportion to the extent that the CS predicted the aversive loud noise (Figure 
3). The cue periods were too short to allow the measurement of HRV (see Methods), while MAP was 
unaffected by the CSs. 
Bilateral inactivation of area 25 or area 32 disrupted this Pavlovian discrimination, and revealed that these 
areas have opposing roles in the evaluation of, or the expression of the response to, emotionally 
significant stimuli (Figure 4). Area 25 inactivation reduced anticipatory negative emotional responding: 
the cardiovascular and behavioral responses were attenuated in a CS-dependent manner, with the 
response to the CS fully predictive of aversive noise decreasing the most (Figure 4A/D). This pattern was 
mirrored by systemic diazepam, an anxiolytic drug (Figure 4C/F). These findings were not due to a change 
in overall locomotor activity impacting upon cardiovascular activity (see Figure S2/ Methods). Neither 
were they due to a generalised blunting of cardiovascular reactivity, or to changes in arousal, as the 
magnitude of the unconditioned arousal response to the loud noise was unaffected by drug treatment 
(Figure 5). Muscimol/baclofen did not affect US-induced HR changes in either area 25 or 32, and nor did 
diazepam.  
In contrast to the reduction in conditioned negative responding following area 25 inactivation, area 32 
inactivation increased negative emotional responding. The HR and behavioral responses were increased 
in a non-CS-specific manner, with a generalisation of the negative emotional responses (previously only 
seen to the most aversive CS) to the mid and least aversive CSs. 
 
Area 25 inactivation enhances, and area 32 inactivation impairs, fear extinction 
The findings from the aversive discrimination are consistent with data from human neuroimaging 
suggesting that activity within area 25 is associated with increased negative affect, and activity within area 
32 is associated with increased positive affect. However they are inconsistent with data derived from the 
rodent fear conditioning literature in which the suggested function of the rodent PL is to enhance negative 
emotion, while the IL acts to reduce it. It is possible that the observed inconsistencies could be due to 
differences between our mildly aversive discriminative fear paradigm – which uses multiple auditory cues, 
requires substantial training and does not investigate extinction – and rodent paradigms, which use a 
single cue to predict footshock and which are learnt in one session. We therefore adapted the classic 
rodent paradigm for use with marmosets by replacing the rodent US (footshock) with the sight of a plastic 
snake (see figure 6). Snakes are natural predators of marmosets and are ethologically, highly aversive 
stimuli (43) that are commonly used in laboratory tests of negative emotion (44). Snake stimuli also resist 
habituation (45), making them suitable for within-subjects investigation of the behavioural and 
cardiovascular effects of saline or muscimol/baclofen infusions into areas 25 and 32 as before. 
As in the rodent paradigms, animals acquired a general (cue + context) conditioned behavioural response 
(vigilant scanning, VS) in one session that slowly extinguished under saline the next day and was followed 
by subsequent reinstatement and re-extinction of the conditioned response. They also showed a general 
conditioned cardiovascular response, with MAP showing a similar pattern (HR also increased but it was 
too variable to use as a measure of conditioning). These responses were stable across the repeated blocks 
of conditioning, which were distinguished from one another by having distinct contextual backgrounds, 
and were readily extinguished under saline conditions (see Figure 7). 
 
As with the discrimination findings, bilateral inactivation of area 25 or area 32 during extinction revealed 
that these areas have opposing roles in the regulation of fear extinction responding (Figure 7). Compared 
to saline, inactivation of area 25 enhanced fear extinction of VS and MAP fear responses, indicating a 
reduction in fear (Figure 7A). In contrast, inactivation of area 32 did not affect the gradient of extinction 
for MAP but appeared to delay the extinction of VS such that VS increased across the early stage of 
extinction before it began to decline (Figure 7B). This VS increase also persisted throughout the next 
session when marmosets were tested for recall of extinction while drug-free. Recall was unaffected by 
area 25 inactivation. These effects on extinction were not due to an alteration in the ability of marmosets 
to express conditioned fear, as there was no difference in VS or MAP during the first CS pair of the 
extinction session after either manipulation. Thus area 25 inactivation reduces the autonomic and 
behavioural components of the conditioned fear response to enhance extinction, while area 32 




Using a novel experimental approach that takes into account brain-body interactions, the present study 
uses two different fear conditioning paradigms to show that area 25 inactivation reduces the behavioural 
and cardiovascular correlates of conditioned fear, and area 32 inactivation increases them via 
overgeneralisation. They provide the first causal evidence in primates to support the hypothesis that area 
25 activity promotes negative affect and area 32 activity reduces negative affect, in both the behavioural 
and autonomic domains of emotion. These findings show remarkable similarity to correlative human 
imaging studies in which negative affect (both induced and pathological) is associated with activity in a 
subgenual, posterior ventromedial region centred on area 25, while positive affect is associated with 
activity in a distinct, more anterior region that includes areas 32, 24 and 10 (12). They also provide the 
first causal evidence that activity in area 25 regulates cardiovagal control in both the resting state (neutral 
condition) (compare , 46), and during alterations in emotional states in healthy subjects (aversive 
Pavlovian discrimination) (compare , 47). 
The finding that area 32 inactivation in a primate caused overgeneralisation of emotional responses (in 
both the conditioned fear discrimination and single cue fear extinction paradigms) suggests that area 32 
normally suppresses such generalised fear responding. Behavioural overgeneralisation of fear is a 
characteristic symptom of negative emotion and is seen in anxious humans (48), anxious marmosets (41) 
and anxious rats (49, 50), and has been associated with perigenual vmPFC (areas 10/24/32) hypoactivity 
in humans (51). We now causally link area 32 hypoactivity to such overgeneralisation in primates. When 
compared to the more limited autonomic effects of area 32 inactivation in emotionally neutral conditions, 
the discrimination findings provide support for human neuroimaging data that implicate area 32 in 
cardiovascular modulation during emotion regulation (see also , 52), and less in the tonic regulation of 
cardiovascular activity in non-emotional situations (13). In contrast to area 32, area 25 inactivation not 
only regulated the emotional responding induced by external stimuli, but also had profound effects on 
cardiovascular activity in an emotionally neutral condition, decreasing HR and MAP but also increasing 
CVI, the component of HRV that is reduced in both anxiety and depression (eg. , 15, 53). Furthermore, the 
demonstration that area 25 inactivation reduces anticipatory negative emotional responding and 
increases resting CVI suggests that area 25 overactivity directly contributes to the maladaptive and 
emotional inflexibility seen in such disorders. This may explain aspects of the strong bidirectional 
relationship between depression and cardiovascular disease (14, 54). 
It is notable that HR (and not MAP) was more tightly linked to conditioning in the fear discrimination 
paradigm, but MAP (and not HR) was more tightly linked to conditioning in the fear extinction paradigm. 
Although it is aversive, the noise US used in the fear discrimination is not an ethologically relevant 
stimulus, and is therefore less likely to trigger a fight or flight response than the highly ethologically-
relevant snake US used in the fear extinction paradigm. In contrast to HR, which is primarily controlled by 
the parasympathetic nervous system, MAP and fight or flight responses are predominantly 
sympathetically mediated, which may explain the dominance of the MAP response to the snake. The 
increase in MAP and HR seen after area 32 inactivation during negative emotional provocation is 
consistent with the autonomic activation and area 32 hypoactivity seen in some forms of anxiety (51). 
As such, the convergence between the current findings in marmosets and human data is a marked 
improvement on the discrepancies between the rodent and human data. As judged by the dominant 
theory of rodent/primate vmPFC homology (55), our behavioural results differ from the large body of 
rodent fear conditioning studies in which inactivation of the putative rodent homologs of area 25 (the 
infralimbic cortex, IL) and area 32 (the prelimbic cortex, PL) have the opposite effects to that seen in 
marmosets, increasing and reducing negative emotional responding respectively (26, 31). It is possible 
that the anatomical similarity between IL/25 and PL/32 (24) may not translate into equivalent 
functionality, or that the functional role of IL and PL in fear conditioning and extinction is more complex 
than initially proposed (56). Certainly, the focus on negative emotion ignores similar roles for these 
regions in the recall and expression of positive emotion (57), in the control of goal directed instrumental 
responding (58, 59) and in social cognition (60). It has been suggested that the function of the PL region 
transcends fear expression and appetitive goal-directed instrumental responding, and is important in the 
ability to attend selectively to the elements of the environment that best predict an outcome, be it 
discriminating between a cue and its associated context in a simple Pavlovian paradigm using a single cue 
(46) or between two cues of a compound stimulus in a Pavlovian overshadowing procedure (61). Such a 
hypothesis could explain the generalised increases in conditioned fear responses seen here after 
inactivation of area 32 in fear extinction. However it remains to be determined whether it can explain the 
situation seen in the discriminative fear conditioning paradigm, where animals with inactivation of area 
32 did not generalise conditioned fear responses to the context but instead showed generalisation from 
a CS+ to a CS-. IL, in contrast, has been implicated not only in inhibiting Pavlovian conditioned fear and 
conditioned appetitive responses during extinction in rodents (26), but also in attenuating the influence 
of goal directed behavior when this conflicts with habitual stimulus-response associations (62). Of note, 
ablations of area 25 in a rhesus monkey alter the autonomic coding of appetitive stimuli (63). Recent 
reviews have attempted to reconcile these two aspects of IL function, particularly given that IL is central 
to visceromotor/autonomic circuits, and proposed that IL may ‘allow’ state-based habits to dominate 
behavior  (64, 65). If so, the inconsistency of our results with current findings in rodents suggests that at 
the very least, more work is need to determine how IL/area 25 inactivation can induce opposing effects 
on fear extinction across rodent and marmoset studies. Alternatively we need to rethink the current views 
on cross species functional similarities and its translational implications. 
Our understanding of the contribution of these areas to cardiovascular modulation is more limited, but 
both IL activation or PL inactivation have been shown to suppress the cardiovascular responses to acute 
restraint stress (21, 66) – again suggesting that these regions have opposing effects in rats, but in the 
opposite direction to that in marmosets and humans. Furthermore, in direct contrast to the cardiovascular 
alterations seen in the neutral condition in the present study, manipulations of the rodent medial PFC are 
consistently reported to have no effect on HR or BP in emotionally neutral resting conditions (21, 66).  
In summary, we have isolated the specific contributions of areas 25 and 32 of the primate anterior 
cingulate cortex to the regulation of the cardiovascular and behavioural components of negative emotion. 
These results provide mechanistic insight into the correlative human imaging studies that implicate these 
regions in the regulation of negative emotion. This insight will be vital for understanding how dysfunction 
within areas 25 and 32 contributes to the behavioural and physiological symptomatology of emotion 
dysregulation in depression and anxiety, and how current and novel treatments may be better targeted. 
We demonstrate the utility of a novel primate model to study complex brain-body interactions, and 
highlight its importance for our understanding of the neural basis of affective processing. 
 
 
Materials and Methods 
Subjects and Housing 
Seventeen experimentally naïve marmosets (Callithrix jacchus, 8 female, 9 male), bred on-site at the 
University of Cambridge Marmoset Breeding Colony, were housed in male/female pairs (males were 
vasectomised). Of these, 13 were used in the present studies, and 4 are referred to in the Supplement 
(see table S1). They were kept in a 12 hour light-dark cycle (lights on at 7am, lights off at 7pm) in a 
controlled environment of 22 ± 1ᵒC in temperature and 50 ± 1% humidity. Their cages contained a variety 
of environmental enrichment aids including suspended ladders, wooden branches and ropes to climb and 
swing on, and boxes to play in. Animals were fed a varied diet including fruit, rusk, malt loaf, peanuts, 
eggs, sandwiches and weekend treats and they had ad libitum access to water. All procedures were carried 
out in accordance with the UK Animals (Scientific Procedures) Act 1986 and the local Animal Welfare and 
Ethical Review Board. 
 
Behavioural Testing Apparatus 
Behavioural testing took place within a sound-attenuated box in a dark room. Animals were trained to 
enter a transparent Perspex carry box in which they were transported to the behavioural test apparatus. 
The Perspex carry box was placed inside the test chamber, and the marmoset remained inside this box at 
all times during testing. The test chamber was lit by a 3W bulb (houselight), located in the middle of the 
ceiling of the chamber and contained a computer-controlled speaker and a siren generator (120dB; 
Biotronix, Cambridge) through which auditory stimuli and a siren could be played. The apparatus was 
controlled by the Whisker control system (67) and in-house software (R. Cardinal).  Three video cameras 
were positioned in the test chamber so that the movement of the animal within the Perspex box could be 
recorded by video software (CyberLink, Power Director, CyberLink Corp.). The video display was also 




All animals underwent two aseptic surgical procedures, one to implant intracerebral cannulae targeting 
either the area 25, area 32, or both, and one to implant a telemetric blood pressure monitor into the 
descending aorta. Both surgeries were completed prior to the animal beginning any behavioural testing.  
Cannulation Surgery 
Marmosets were pre-medicated with  ketamine hydrochloride (Vetalar; 0.05 ml of a 100 mg solution, i.m.; 
Amersham Biosciences and Upjohn, Crawley, UK) before being given a long lasting non-steroidal, anti-
inflammatory analgesic (Carprieve; 0.03ml of 50mg/ml carprofen, s.c; Pfizer, Kent, UK). They were 
intubated and maintained on 2.0–2.5% isoflurane in 0.3 l/min O2 and placed into a stereotaxic frame 
modified for the marmoset (David Kopf, Tujanga, CA). Pulse-rate, O2 saturation, breathing rate, and CO2 
saturation were all monitored by pulse-oximetry and capnography (Microcap Handheld Capnograph, 
Oridion Capnography Inc., MA, USA), and core body temperature was monitored by a rectal thermometer 
(TES-1319 K-type digital thermometer, TES Electrical Electronic Corp., Taipei, Taiwan). Cannulae (Plastics 
One, Roanoke, VA) were implanted into the sgACC (26 gauge double cannulae, 7mm long, 1mm apart, 
Anteroposterior[AP] +14, Lateromedial [LM] +/- 0.5) and the pgACC (double cannulae, 2mm long, 1mm 
apart, AP +17, LM +/- 0.5 at a 30O AP angle) adjusted where necessary in situ according to cortical depth 
(68). Postoperatively, and when fully recovered, all monkeys were returned to their home cage and then 
received the analgesic meloxicam (0.1 mL of a 1.5 mg/mL oral suspension; Boehringer Ingelheim) for 3 
days after which they had at least a further 10 days recovery. Cannulae were cleaned every week (and 
caps and cannula blockers changed) to ensure the cannula site remained free from infection. 
Telemetry Probe Surgery 
Animals were anaesthetised as before, the descending aorta visualised within the abdominal cavity and 
the probe catheter of a telemetric blood pressure transmitter (Data Sciences International [DSI], St. Paul, 
MN, USA) implanted into the aorta just about the aortic bifurcation as described previously (35).  All 
monkeys received meloxicam as before in addition to prophylactic treatment with amoxicillin and 




For all sterile drug treatments the marmoset was held gently in a researcher’s hand. For central infusions, 
the caps and cannula blockers were removed from the guide, and the site was cleaned with 70% alcohol. 
A sterile injector (Plastics One) connected to a 2 μl gas tight syringe in a syringe pump was inserted into 
the guide cannula and 0.5μl of saline or 0.5μl of 0.1 mM muscimol/1.0 mM baclofen was bilaterally infused 
at a rate of 0.25 μl per minute. Following the infusion, the injector was left in place for a further minute 
to allow the drug to diffuse before injector removal. Sterile cannula blockers and caps were replaced and 
the marmoset was returned to its homecage for 25 minutes. For peripheral injections, the injection site 
was cleaned with alcohol and injected with either diazepam (0.25 mg/kg, i.m.; Wockhardt Ltd.) or an equal 
volume of saline vehicle 30 min before testing. All cardiovascular and behavioural effects of drug 
treatments had returned to normal by the subsequent testing session. 
 
Behavioural Testing Paradigms 
1. Neutral Condition 
After full recovery from both telemetry surgery and cannulation surgery, monkeys were habituated to the 
test apparatus for 4-8 fifteen-minute sessions during which time they were positioned inside the Perspex 
carry box in the test apparatus with the light on. No sounds were played. The number of habituation 
sessions was dependent on how quickly they acclimatised to the test apparatus. Each monkey was 
considered to be habituated when their heart rate did not change from one habituation session to the 
next, and they were observed to be completely calm for the whole session. They then received additional 
identical 15 minute sessions, prior to which they received infusion of saline or muscimol/baclofen into 
either area 25 or 32. Infusion days were interspersed with days when the animal was given a test session 
without an infusion to ensure any alterations in cardiovascular activity had returned to normal. All 
marmosets took part in the neutral condition. 
2. Discrimination Condition 
In contrast to most rodent fear conditioning paradigms which use a simple, single cue to predict electric 
shock presentation (26), here we use a milder, discriminative fear conditioning paradigm with multiple 
cues associated with different probabilities of aversive loud noise. 
During each session, the animal was positioned inside the Perspex carry box within the testing apparatus 
and the houselight was on. Before the discrimination started, each animal received a probe session in 
which they were given with 4 presentations each of three distinct auditory conditioned stimuli (CSs; clicks, 
10 clicks per second at 75 dB; intermittent tone, 440 Hz, 1 sec on, 0.1sec off at 75 dB; white noise at 75 
dB). The innate, unlearned responses to each CS were assessed according to response magnitude 
(behavioural and cardiovascular). The CS that resulted in the largest response became CS1 and was paired 
with the least aversive US. The CS with the smallest response became CS3 and was paired with the most 
aversive US. The intermediate CS became CS2. This was to ensure that the discriminative responses shown 
by the animal were conditioned responses and not innate. Upon commencing the discrimination, each 
session contained twelve trials, with each trial consisting of the presentation of one of the three CSs (20s, 
70-75dB), and the presentation of an unconditioned stimulus (US) immediately afterwards. The US was 
either a mildly aversive loud siren (117-120dB, 0.4-0.7s) or a non-aversive brief period of darkness (0.4s).  
These were combined to make 3 CS-US pairs that varied in aversivity (valence) and were each presented 
4 times per session: CS1 was always followed by the mildly aversive siren, CS3 was always followed by the 
non-aversive darkness, and CS2 was followed on 50% of trials by the siren, and by darkness on the other 
50%. The trials were presented in a pseudorandom order with a variable intertrial interval (ITI = 100-160s) 
and the three different CS-US pairings were counterbalanced across animals. Of the 9 animals who went 
on to learn the aversive discrimination, one animal failed to learn it and was dropped from the study. 
For each trial, the mean heart rate (HR) was calculated for the 20 sec CS presentation and for the 
immediately preceding 20 sec baseline (BL) period (the last 20 seconds of the preceding intertrial interval).  
For each CS presentation, the CS-specific HR was calculated as (HR during the CS) – (HR during BL). 
Significant discrimination performance was defined as a difference in CS-directed HR between the most 
aversive and the least aversive CS that was statistically significant (within data from that subject) across 
two consecutive sessions. Upon reaching discrimination criterion, the marmoset received a drug 
treatment before testing on the next two test sessions. This could be central infusions or peripheral 
injections of diazepam. Following this, animals were required to regain discrimination criterion before 
another infusion was performed. Two animals failed to regain significant discrimination performance after 
peripheral diazepam treatment which meant that the effect of peripheral saline could not be assessed.  
For this reason the diazepam results are compared to the effects of saline infusions into area 32, as it was 
the most recent, and therefore comparable, saline treatment in those animals.  
3) Fear conditioning and extinction 
Animals were given four cycles of fear conditioning, extinction and recall. Each cycle consisted of five 
sessions, spread over 5 consecutive days; two sessions of habituation to the context, one session of fear 
conditioning, one session of fear extinction, and one session of extinction recall. During each session, 
animals were positioned inside the Perspex carry box within the testing apparatus as before, but each 
time the cycle was repeated there was a different context. This was achieved by covering the inside of the 
testing apparatus with distinctive black and white patterned screens. For the two habituation sessions 
animals were given 12 unconditioned stimulus (US) presentations whereby a sliding door was opened to 
reveal a hidden chamber, for 5s.  The animal was then given one session of fear conditioning; 12 trials 
consisting of the presentations of an auditory conditioned stimulus (CS, 25s, 70-75dB), paired with a US 
presentation which started 20s after CS onset, so that the last 5s of the CS was concurrent with the 
duration of the US. There was a variable inter-trial interval of 110-130s. The first five CS presentations 
were paired with a US-- where the sliding door was opened to reveal a hidden chamber; however, the 
subsequent seven CS presentations were paired with a US+ where the sliding door opened to reveal a 
hidden chamber containing a life-like plastic cobra snake. The following day, the animal had a session of 
fear extinction: 20 trials consisting of the presentation of the CS-US- pairing, on a variable inter-trial 
interval of 60-80s. Finally, the animals were given a session to test for recall of fear extinction: 15 trials 
consisting of CS-US- pairing, on a variable inter-trial interval of 60-80s.  
Data Analysis 
Telemetry data collection and analysis  
Blood pressure (BP) data was continuously transmitted by the implanted probe to a receiver for offline 
analysis using Spike2 (Version 7.01, CED), as described previously (35). Any outliers and recording failures 
in the data were removed (blood pressure values above 200 mmHg or below 0 mmHg, or other abnormal 
spikes). Data collection was reliable overall, but data gaps of less than 0.4s were replaced by cubic spline 
interpolation and gaps of more than 0.4s were treated as missing values. Systolic and diastolic BP events 
were extracted as local maxima and minima for each cardiac cycle. For the neutral condition, mean arterial 
blood pressure (MAP) was calculated from the systolic and diastolic blood pressure for each cycle using 
MAP = diastolic BP + (1/3 (systolic BP – diastolic BP)). To obtain HR and heart rate variability (HRV) 
measures for the 15 minute duration of the neutral condition, the interbeat intervals (IBIs, calculated as 
the time interval between systolic BP events) were imported to Kubios HRV version 2.1 (69) and were 
corrected for artefacts, using the low artefact correction setting. In contrast to the low setting, artefact 
correction with the strong setting increases the risk of accidental elimination of valid data. Analysis with 
the strong setting, however, did not change the results (see Supplement). Average HR and HRV (root mean 
squared standard deviation (RMSSD) of the time difference between consecutive IBIs, a time-domain 
measure of HRV) were calculated for each session. In order to assess indices of vagal and sympathetic 
activity, Poincaré plots (plot of IBIj+1 as a function of IBIj) were created in Kubios. The standard deviation 
of the points perpendicular to the line of identity (SD1), and the standard deviation of the points along 
the line of identity (SD2) (70) were used to derive indices of autonomic activity; the cardiac vagal index 
(CVI) and the cardiac sympathetic index (CSI) (37). HRV analysis requires a certain number of IBI pairs to 
be valid (approximately 100). While the 15 minute session of the neutral condition is ample (an average 
of 14000 IBIs), it was therefore not possible to calculate HRV measures in response to the 20 s cue 
presentations in the fear discrimination or fear extinction paradigms. There was no evidence that animals 
deviated from sinus rhythm (see Supplement). 
Behavioral analysis 
Behavior during the discrimination was recorded and subsequently scored by an experimenter. The 
specific behavior scored was vigilant scanning (VS), defined as CS-related anxious-like behaviours including 
watchful scanning of surroundings accompanied by tense, vigilant body posture (71, 72). The time the 
animal spent engaged in this behavior during the 20s CS period and 20s BL period was scored. CS-specific 
VS was calculated as the difference between these two (exactly as for CS-specific HR). A second person 
blind to the conditions of the experiment scored a subset (one in five) of the discrimination sessions. 
Interscorer reliability was high (r480 = 0.817, P < 0.005). For control purposes, overall locomotor activity 
(defined as the duration of movement including translational movement with all four paws moving and 




For the neutral condition, the average HR and MAP were calculated for the 15 min session, and this data 
used to calculate the HRV as before.  It was not possible to quantify VS during the neutral condition.  This 
is because VS is by definition, CS-related, and because the neutral condition did not include any CSs, there 
was no VS. 
For the discrimination, each monkey’s CS-directed HR or VS during the experimental manipulation days 
(saline, muscimol/baclofen or diazepam) was standardized to the same monkey’s CS-induced heart rate 
during the preceding 2 day block of baseline behaviour, using y' = (y - y_mean) / y_SD, where y =  individual 
CS-induced change in HR or VS during experimental days, y' =  standardized y, y_mean  =  subject’s own 
mean CS-induced change in HR or VS during baseline days and y_SD = subject’s own standard deviation 
of CS-induced change in HR or VS during baseline days. This was done because of substantial inter-monkey 
variability in baseline HR/VS and the magnitude of HR/VS changes. Within-subject standardization 
therefore increases the power to detect drug-induced changes. A small number of CS datapoints were 
removed from the dataset due to animals vocalising during the BL or the CS, which materially changed the 
HR. In all cases the VS/HR during a 20 sec CS was also compared to the immediately preceding 20 sec 
baseline period. This was so that any changes seen in the neutral condition could be eliminated from the 
discrimination data analysis: e.g. where area 25 inactivation reduced HR in the absence of cues, it would 
do so across the whole session and affect both baseline and CS periods equally. Thus, any measured 
changes in CS responses were due to the altered interpretation of the CSs and not due to an overall 
reduction in HR.  For the US analysis the period around the onset of the US was compared to the last 5 
seconds of the baseline and averaged across all 8 of the most aversive CSs.  The peak US-induced HR 
increase was then compared to the HR immediately preceding the US onset. 
ANOVA was performed with R version 3.2.2 (73) using the lme4 package for linear mixed-effects 
modelling, statistical tests from the lmerTest package and type III sums of squares with the Satterthwaite 
approximation for degrees of freedom (here reported to the nearest integer). 
For the discrimination, area (sgACC or pgACC) and manipulation (saline vs drug) were both factors, and CS 
valence was a linear/continuous predictor (-1 least, 0 mid, 1 most). The assumption of a normal 
distribution of residuals was verified with the Shapiro-Wilk test. In 2 analyses (the impact of drug infusions 
on CSI on the neutral condition, and the impact of saline infusion on visual scanning at baseline) there 
were marginal violations of the normality assumption (p < .05), which were minor as judged by a Q-Q plot, 
and to which ANOVA is robust (74). Alpha was controlled per ANOVA and for all sub-analysis thereafter, 
as is the norm (74). 
 
For the fear extinction the overall mean ΔMAP during CS 2-6 of the conditioning sessions (when the animal 
is expecting the US-) was subtracted from the remaining data points for each subject, to normalise each 
subject’s snake conditioning scores to their own individual MAP baseline. This was due to high inter-
individual variability in MAP. CS1 was not used as it was the first time the animal had heard that CS and 
could therefore be confounded by novelty-induced arousal.  ΔVS was calculated the same way.  
For analysis of both ΔMAP and ΔVS data, trials were averaged in trial blocks of two (26). ANOVA was 
performed to analyse the effects of area 25 and area 32 infusions on the CS ΔMAP/VS responses with R 
as above. Area (25 or 32), drug treatment (saline or muscimol/baclofen) were discrete factors, and subject 
a random factor. For analysis of conditioning and recall sessions CS-trial block was analysed as a discrete 
factor. However, for the purpose of analysing the gradient of extinction, CS-trial group was treated as a 
linear predictor. For analysis of CS-directed effects, the scores for the preceding 20 sec baseline (the last 
20s of the ITI) were subtracted from the CS scores without normalisation to CS2-6 (the comparison to 
baseline providing the normalisation). 
Since all animals had at least four repeats of conditioning, extinction and recall, an ANOVA was performed 
to assess whether this repetition affected the acquisition of fear conditioning. As conditioning took place 
without any infusions, each animal’s first four conditioning sessions were included in this analysis, even if 
the extinction and recall data was not analysed further. 
 
Post mortem assessment of cannulae placement 
Animals were premedicated with ketamine hydrochloride (Vetelar; 0.05 ml of a 100 mg solution, i.m.; 
Amersham Biosciences and Upjohn, Crawley, UK) before being euthanized with pentobarbitol sodium 
(Dolethal; 1ml of a 200mg/ml solution, i.v.; Merial Animal Health, Essex, U.K.). Animals were then perfused 
transcardially with 500ml 0.1M PBS, followed by 500ml of 4% paraformaldehyde fixative solution, over 
approximately 15 minutes. The brain was removed and left in the 4% paraformaldehyde fixative solution 
overnight before being transferred to 30% sucrose solution for at least 48 hours. Brains were then 
sectioned on a freezing microtome (coronal sections; 60µm), mounted on slides, and stained with cressyl 
fast violet. The sections were viewed under a Leitz DMRD microscope (Leica Microsystems, Wetzlar, 
Germany). The cannula locations for each animal were schematized onto drawings of standard marmoset 
brain coronal sections and composite diagrams were then made to illustrate the extent of overlap 
between animals.  
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Figure 1: Behavioral conditions and prefrontal cortex cannulae.  A. In the neutral condition (n=13), 
animals were placed in a familiar environment for 10 min in the absence of any cues.  B. In the 
discrimination condition (n=7), animals were played three distinct conditioned stimuli (CSs) that were 
followed probabilistically by two distinct outcomes (unconditioned stimuli; USs) that varied in 
aversiveness (C). D. Experimental sequence. Monkeys experienced the neutral condition before learning 
the aversive discrimination E. Each 20 second CS was presented four times in a pseudorandom order, with 
an intertrial interval (ITI) of 100-160 secs. F. Glass brain illustrating the rostro-caudal locations of area 25 
and area 32 and the double intracerebral cannulae targeting each area. G. Representative histological 
sections with arrows marking the position of the cannulae tips and cannulae locations for each animal. All 
area 32 cannulae were located within the range of AP 15.8–16.6 and all area 25 cannulae were located 
within the range of 12.5-14, plotted here on a single coronal section for each target area. Black circles 
indicate animals within the neutral condition only (area 25, n=6; area 32, n=7) and gray circles indicate 
the animals within both the neutral condition and the discrimination (area 25, n=4; area 32, n=4). 
Cytoarchitectonic parcellation was based on (73). The circles represent the estimated maximal spread of 
the muscimol/baclofen or saline infusions (74). 
 
Figure 2.  Inactivation of area 25 and area 32 had differential effects on cardiovascular activity in an 
emotionally neutral environment.  Compared to saline, anatomically selective inactivation of area 25 and 
area 32 with muscimol/baclofen (musbac) had different effects (area x treatment) on each of HR (beats 
per minute; F1,17.7 = 5.966, P= 0.025, η2 =0.052), MAP (mmHg; F1,18 = 17.9, P= 0.0004, η2 = 0.09) and HRV 
(F1,17.8 = 7.514, P= 0.013, η2 =0.052). Area 25 inactivation decreased HR (F1,5 = 19.151, P= 0.007, d=2.01) 
and MAP (F1,5 = 6.32, P= 0.05, d=1.61 ) and increased HRV (F1,5 = 10.392, P = 0.023, d=1.17). The HRV 
change was due to an increase in the cardiac vagal index (CVI; F1, 5 = 8.1436, P= 0.035, d=0.61) without 
change in cardiac sympathetic index (CSI; F1,19.1 = 1.2, not significant [NS]). In contrast, area 32 inactivation 
increased MAP only (F1,9.99 = 12.4, P= 0.0052, d=0.36; HR and HRV: F < 1, NS). Bars show mean ± standard 
error of the mean (SEM); SED: standard error of the difference for the interaction term; *P < 0.05. 
 
Figure 3: Animals learned to discriminate the three conditioned stimuli (CSs) and this discrimination 
was not disrupted by central infusions of saline. A. Example learning traces from one animal show how 
the traces separate out as learning progresses, with CS-directed heart rate increases (in beats per minute; 
bpm) that mirror the aversiveness of each CS. In each case the heart rate during the CS is compared to 
the last 20 seconds of the preceding ITI (the ‘baseline’). Criterion was defined as displaying a significant 
difference in HR between the most and least aversive CSs across two consecutive days of testing. Central 
infusions commenced once the criterion had been reached. Saline infusion into either area 25 or area 32 
did not disrupt the significant heart rate (B) or behavioral (C) discriminations.  Baseline values were 
averaged across both areas, and before both drug and saline manipulations (therefore 4 baselines per 
animal; baseline discrimination: heart rate, F1, 13 = 7.4, P= 1.6 x 10-6, d = 2.6 ; vigilant scanning, F1, 13 = 104.03, 
P= 1.43 x 10-7, d =2.7). Saline infusions were averaged across each area (therefore 2 saline treatments per 
animal; saline discrimination, heart rate, F1, 13 = 34.94, P= 5x 10-5, d = 1.8; vigilant scanning, F1, 13 = 24.47, 
P= 0.00026, d = 1.8). Saline infusions did not disrupt discrimination performance (all terms including 
treatment (saline or baseline); P> 0.05, NS). The number of dots on each column indicate the per-subject 
mean for each baseline/saline treatment; the discriminative response remained stable during the 
experiment.  * P<0.05. Least, mid, most refer to the CS aversiveness; n=4 for each area. 
 
Figure 4: Area 25 inactivation and diazepam treatment abolished the increases in heart rate (HR) and 
vigilant scanning (VS) induced by conditioned stimuli (CSs) associated with aversive outcomes, with 
effects that were more pronounced as the CSs became more predictive. Area 32 inactivation caused 
overgeneralisation in a way that did not depend on the CS. Main figures show the CS-induced change in 
HR or VS, under drug and saline conditions, relative to the last 20 seconds of the immediately preceding 
ITI (the ‘baseline’), standardized to that subject’s own variability (measured independently; see Methods). 
Positive numbers indicated an increase in HR or VS from baseline, while negative numbers indicate a 
decrease compared to baseline. * P< .05, # P< .05 manipulation x CS interaction, † P< .05 main effect of 
manipulation. SED shown is for the drug × CS interaction; n = 4. Insets show the drug-induced changes 
relative to saline (error bars: SEM; L/Mi/Mo, least/middle/most aversive CS). A, D: Area 25 inactivation 
with muscimol/baclofen abolished discrimination, altering responding in a CS-dependent manner, as 
assessed by CS-induced changes in HR (drug × CS, F1,17 = 5.11, P= .037, η2 = 0.117; effect of CS during 
inactivation, F1,7 = 1.87, NS) and VS (drug × CS, F1,17 = 7.84, P= .012, η2 =0.113; effect of CS during 
inactivation, F1,7 = 1.57, NS). Discrimination was retained under saline infusion (effect of CS: P = .009, η2 = 
0.557 for HR and .0003 for VS, η2 = 0.685). These effects differed from those of area 32 inactivation (HR: 
drug × area, F1,34.7 = 14.7, P= .0005, η2 = 0.165; VS: drug × area, F1,33.4 = 24.2, P= .00002, η2 =0.198). B, E: 
Area 32 inactivation similarly impaired discrimination, but here the effects of inactivation were not 
specific to a particular CS (HR: drug, F1,20 = 16.3, P= .00065, η2 = 0.384; drug × CS, F1,20 = 2.50, P= .129, η2 
=0.059; effect of CS during inactivation, F < 1, NS; VS: drug, F1,17 = 5.27, P= .035, η2 =0.107; drug × CS, F1,17 
= 2.45, P= .136, η2 =0.050; effect of CS during inactivation, F1,10 = 3.3, P= .099, η2 =0.248). Discrimination 
was similarly retained under saline (P= .0047 for HR, η2 =0.566 and .0125, η2 = 0.473 for VS). C, F: Systemic 
diazepam (0.25 mg/kg) impaired discrimination by altering responding in a CS-dependent manner (HR: 
drug × CS, F1,20 = 3.77, P= .066, η2 = 0.085; drug, F1,20 = 7.97, P= 0.011, η2 =0.180; VS: drug × CS, F1,17 = 8.16, 
P= .011, η2 =0.159), similar to the effects of area 25 inactivation. 
 
Figure 5. The US response to the most aversive CS is unaffected by inactivation of area 25, area 32, or 
diazepam treatment, indicating that alterations specifically in conditioned, but not unconditioned, 
negative arousal are responsible for the alterations in heart rate seen during CS presentation. US-
induced change in heart rate (HR, beats per minute; bpm) under drug (muscimol/baclofen and diazepam) 
and saline conditions, relative to the last 5 seconds of the baseline. Data is shown for the last 4 seconds 
of the CS and the first 4 seconds after the US onset at the 40 second time point (see Supplementary) and 
is the mean of the 8 presentations of the CS fully predictive of the aversive US for each condition.  Inset: 
the absolute change in HR response (the difference between HR at US onset and the peak HR response). 
Repeated measures ANOVA revealed a significant difference in HR between US onset and US peak (F1,3 
=57.843, P = 0.005, η2 = 0.951) but no interaction with drug treatment (F4,12 =0.663, P = 0.630). There were 
also no significant differences in US-induced HR increases between area 25 saline and area 25 
muscimol/baclofen (t3 =-0.452, P= 0.682), area 32 saline and area 32 muscimol/baclofen (t3 =-0.762, P = 
0.501), or area 25 muscimol/baclofen and diazepam (t3 =0.812, P = 0.476). 
 
Figure 6. Within-subject fear conditioning and extinction paradigm. A. Animals were given four cycles of 
fear conditioning, extinction and recall. Each cycle consisted of five sessions, spread over 5 consecutive 
days: two sessions of habituation to the context, one session of fear conditioning, one session of fear 
extinction, and one session of extinction recall.  On days 1 and 2 (i), animals were given two days of 
habituation where they received 12 presentations of the US- (5 s duration, ITI = 110-130 s; door opens to 
reveal an empty chamber).  On day 3 (ii) marmosets received one session of fear conditioning which 
comprised 5 presentations of an auditory CS (25 s, 70dB) paired with the US-, followed by 7 presentations 
of the same CS paired with the US+ (5 s, ITI=60-80 s; the door opening to reveal the chamber containing 
the plastic snake for the last 5 s of the CS). On days 4 and 5 (iii) the marmosets were tested for extinction 
and recall where the CS was presented in extinction (extinction, 20 CS-US- presentations; recall, 15 CS-US- 
presentations; ITI = 60-80 s). B. Each time the cycle was repeated the inside of the test apparatus was 
covered with distinctive black and white patterned screens to create a different context and a different 
CS cue was used. Contexts, cues and context/cue combinations were counterbalanced across animals. 
 
Figure 7. Area 25 inactivation enhanced the behavioural and cardiovascular correlates of fear 
extinction. Area 32 inactivation impeded behavioural correlates of fear extinction in a way that did 
not depend on the CS. Graphs show the change in VS or MAP under drug and saline conditions, Figures 
ii and iii in each block represent the CS responses irrespective of baseline. Positive numbers indicate an 
increase in HR or VS from baseline, while negative numbers indicate a decrease compared to baseline. * 
P< .05, # P< .05 manipulation x CS interaction, † P< .05 main effect of manipulation, error bars = ± SEM. 
Area 25, n = 3. Area 32 VS, n = 5. Area 32 MAP, n = 4. Ai/Bi. Representative cannulae locations for each 
animal, plotted here on a single coronal section for each target area. A separate cohort of 8 monkeys 
learned this new paradigm. A/B ii and iii. Subjects across both groups acquired conditioned behavioural 
and cardiovascular responses in one session. There was a robust effect of the CS (analysing raw pre-US 
data for the first three CS pairs as a four-level factor, across area 25/32 subjects with area as an 
additional predictor; VS: F1,53.9 = 46.521, p = 8.14 × 10–9, η2 = 0.333; MAP: F1,47.1 = 5.00, p = 0.030, η2 = 
0.018), with no differences in conditioning between subjects by subsequent infusion area (terms 
involving area: F < 1, NS, for both MAP and VS). This response was not altered across repeated 
conditioning cycles (analysing data as before, across all cycle repeats, with repeat and area as additional 
predictors; terms involving repeat, F < 1.64, p > 0.2, NS, both for VS and MAP). These responses were 
readily extinguished under saline treatment in both areas (VS: CS pair, F9, 54 = 6.169, P < 0.001, MAP: F9, 45 
= 5.513, P < 0.001). Aii-iii. Area 25 inactivation with muscimol/baclofen reduced negative emotion by 
enhancing the extinction of both the VS and MAP responses.  There was a greater reduction in the 
expression of VS over the course of the extinction sessions (VS: drug x CS-pair, F1, 54 = 8.297, P = 0.0057, 
η2 = 0.030, Aii) and a trend towards a greater decrease in MAP (drug x CS-pair, F1, 54 = 3.046, P = 0.08661, 
η2 = 0.012, Aiii). These effects were not due to an effect on marmosets’ ability to express conditioned 
fear, as there was no difference in VS/MAP during the first CS-pair of the extinction session (VS: t2 = 
0.48; P = 0.678, MAP: t2 = -0.32843, P = 0.7738), and were different from those of area 32 inactivation 
(VS: area x drug x CS-pair: F1, 146 = 6.233, P = 0.0136, η2=0.011, MAP: drug x CS-pair, F1, 127 = 4.253, P = 
0.0412, η2 = 0.009; area x drug x CS-pair, F1, 127 = 1.205, P = 0.2743). Bii-iii.  Area 32 inactivation also 
altered extinction, but here the effects of inactivation were not specific to the CS-pairs and the gradient 
of extinction was not altered for VS or MAP (VS: drug x CS-pair, F1, 92 < 1; drug, F1, 92 = 1.8140, P = 0.1813; 
MAP, drug x CS-pair F1, 73 < 1). However, given that VS behaviour was much higher after inactivation of 
area 32, a post hoc analysis asked whether inactivation affected VS independently of the extinction 
process. This revealed an extinction-independent increase in general VS (drug, F1, 76 = 128.171, P < 2.2x 
10-16, η2 =0.502; drug x CS-pair, F9, 76 < 1, Bii), and indicates a significant generalised increase in fear 
throughout the session, despite no difference in VS during the first CS-pair of the extinction session (t4 = 
1.13; P = 0.32). This generalised increase in VS (not MAP, Biii) after area 32 inactivation persisted 
throughout the next session when marmosets were tested on extinction recall while drug free, but recall 
after area 25 inactivation was unaffected (area x drug: VS, F 1, 36 < 1; MAP, F 1, 64 < 1. Area 32: VS; drug, F 1, 
52 = 40.69, P = 4.82 x108, η2 = 0.233, drug x CS-pair, F 6,52 < 1; MAP: drug, F 1, 39 < 1. Area 25: drug; VS, F 1, 26 
< 1, MAP, F1, 26 < 1). 
